ZEISS CLINIC 360 Gains FDA Clearance for Eye Care
Jena, Germany, August 19, 2026 ZEISS Medical Technology, part of Carl Zeiss Meditec AG, has announced that the U.S....
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Jena, Germany, August 19, 2026 ZEISS Medical Technology, part of Carl Zeiss Meditec AG, has announced that the U.S....
Coral Gables, Florida, August 18, 2026 Sitero, a global clinical research organization (CRO) and clinical technology company, has announced...
SOUTH SAN FRANCISCO, Calif., August 19, 2025 – Convoke, an AI-native operating system for the biopharmaceutical industry, today announced...
